Search

everythinglearnresearchcommunity

for

Search:↓

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Certain drugs can cause lupus, stopping these drugs is the main treatment. NB-UVB phototherapy clears psoriasis faster when applied three times a week. Monoclonal antibodies and oral pimecrolimus are effective in treating psoriasis. Smoking and drinking are linked to psoriasis in men. No direct link between low iron and hair loss was found. Vaccines are effective against genital herpes and human papillomavirus type 16.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Stress can worsen skin and hair conditions by affecting the skin's immune response and hormone levels.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

The conclusion is that high-potency steroids or tacrolimus are effective treatments for erosive pustular dermatosis of the scalp.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

A girl initially thought to have a psychiatric disorder was later found to have a lupus-related condition, which improved with proper treatment.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Alopecia areata may be linked to imbalanced gut bacteria.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

The document concludes that hair analysis is not good for assessing nutrition but can detect long-term heavy metal exposure.

Using existing drugs for new treatments is cost-effective and safer.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Most lupus patients in the study experienced hair loss, which greatly affected their mental and social well-being.